Learn More About our Award
Learn More About ReNeuron
Update on the Technology Transfer and Supply Agreement with Fosun Pharma
Notice of Results – Analyst meeting and Investor presentation
ReNeuron to present at International Society of Cell and Gene Therapy
Directorate Changes
Appointment of Nominated Adviser and Joint Broker
at 03-07-2022 7:07:00
15 minute delayed share price from London Stock Exchange provided by Euroland.